Stay updated on Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Naples, Italy has been added as a location. Napoli, Italy has been removed.
    Difference
    0.0%
    Check dated 2026-03-27T02:28:36.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a study topic and linked the Genetic and Rare Diseases Information Center as a resources reference. Updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:47:20.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-12T19:42:16.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; the new revision notice shows Revision: v3.4.2 and replaces the previous Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-12T02:45:10.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Footer/site revision updated from v3.4.0 to v3.4.1; no changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:31:19.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Show glossary feature added; page metadata labels updated (Last Update Submitted that Met QC Criteria and No FEAR Act Data); revision bumped to v3.4.0. These are UI/metadata refinements and do not alter core study information, eligibility criteria, endpoints, or results.
    Difference
    0.1%
    Check dated 2026-01-28T21:26:55.000Z thumbnail image

Stay in the know with updates to Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.